Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2.
Alan H BryceE David CrawfordNeeraj AgarwalMaha H HussainHimisha BeltranMatthew R CooperbergDaniel P PetrylakNeal ShoreDaniel E SprattScott T TagawaEmmanuel S AntonarakisAna M AparicioAndrew J ArmstrongThomas P BoikeJeremie CalaisMichael A CarducciBrian F ChapinMichael S CooksonJohn W DavisTanya DorffScott E EggenerFelix Y FengMartin GleaveCelestia HiganoAndrei IagaruAlicia K MorgansMichael J MorrisKatie S MurrayWendy PoageMatthew B RettigOliver SartorHoward I ScherPaul SieberEric SmallSandy SrinivasEvan Y YuTian ZhangPhillip J KooPublished in: JU open plus (2024)
The first annual USPCC meeting identified several areas of controversy in the management of mCRPC, highlighting the urgent need for clinical trials designed to facilitate treatment selection and sequencing in this heterogeneous disease state.